Researchers find an intriguing link between foods + drinks rich in flavonol and staving off dementia.

A study of brain cells in a dish adds to growing evidence that Alzheimer’s disease can be caused by herpes viruses, but antiviral treatment may help stop it

Highlights: Consuming flavonoid-rich foods can keep Alzheimer's disease at bay Foods rich in flavonoids a

Gum disease bacterium was found to travel throughout the body, exuding toxins linked to Alzheimer's disease, rheumatoid arthritis and aspiration pneumonia, reported new findings.

Androgen deprivation therapy is a hormone-suppressing therapy used to treat prostate cancer. New research has found that androgen suppression therapy

Hormone therapy for prostate cancer, known as androgen deprivation therapy (ADT), may increase the risk of developing Alzheimer's disease (AD) and dementia, reports a new study.

More than 35 million people worldwide had dementia in 2010 and this number is expected to exceed 115 million by 2050. This paper reports on the opportunities offered by the informatics revolution and big data to address Alzheimer’s Disease and dementia. This will require careful planning and multi-stakeholder collaboration as technical, administrative, regulatory, infrastructure and financial obstacles emerge.

he former EastEnders actress, 82, is battling Alzheimer's but Christopher says she still manages to make her friends and family laugh.

Legendary Blackburn Rovers coach Tony Parkes broke down in tears during a revealing interview with his daughter about his struggles with Alzheimers.   

Leeza Gibbons, 57, has made it halfway through Celebrity Apprentice, and now she has something else to celebrate. She is set to introduce her newest line of jewelry Wishes & Dreams.

Nora Barton, 96, who has Alzheimer's will tonight fulfil her dream of singing at the London Palladium - becoming the oldest ever contestant on Britain's Got Talent to boot - to prove life isn't for being put on hold.

This drug could help activate these mechanisms that support nerve health and prevent dementia.

Martins, Ralph, author

Despite clinical trial failures, Alzheimer’s research is getting a reboot thanks to increased funding opportunities and new directions in the data.

Interview with Rajendra S. Apte, MD PhD, and Gregory P Van Stavern, MD, authors of Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases

Interview with Richard Mayeux, MD, MSc, author of Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ε4, and the Risk of Late-Onset Alzheimer Disease in African Americans

Interview with Maurice W. Dysken, MD, author of Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial

Interview with Constantine G. Lyketsos, MD, MHS, author of Effect of Citalopram on Agitation in Alzheimer Disease

Interview with Jeffrey L. Cummings, MD, ScD, author of Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

Rudolph Tanzi, PhD, of Harvard University, and Berislav Zlokovic, MD, PhD, of the University of Southern California, discuss what the future holds for Alzheimer Disease research and treatment.